Table 3 Incidence and risk of psoriasis among diabetic patients with or without DR and ESRD.

From: Psoriasis risk in patients with diabetic retinopathy: A nationwide population-based study

Ā 

Psoriasis

Person-years

Psoriasis incidence (per 1000 person-years)

Model 1 HR (95% CI)

Model 2 HR (95% CI)

Model 3 HR (95% CI)

Group

Non-ESRD

43514

10146096.17

4.29

1 (reference)

1 (reference)

1 (reference)

ESRD

278

23991.82

11.59

2.66 (2.36, 2.99)

2.59 (2.30, 2.91)

2.59 (2.30, 2.91)

Group

Non-DR and Non-ESRD

38286

9154365.31

4.18

1 (reference)

1 (reference)

1 (reference)

Non-DR and ESRD

164

15307.50

10.71

Ā 

2.47 (2.12, 2.88)

2.47 (2.11, 2.88)

DR and Non-ESRD

5228

991730.87

5.27

Ā 

1.22 (1.19, 1.26)

1.22 (1.19, 1.26)

DR and ESRD

114

8684.32

13.13

Ā 

2.98 (2.48, 3.59)

2.99 (2.49, 3.59)

  1. CI: confidence interval; DR: diabetic retinopathy; ESRD: end-stage renal disease; HR: hazard ratio.
  2. Model 1: adjusted for age and gender.
  3. Model 2: adjusted for model 1 + smoking, drinking, regular physical activity, and income level.
  4. Model 3: adjusted for model 2 + body mass index, fasting glucose, hypertension, and dyslipidemia.